ACS report: “Alarming” health disparities in preventable cancers persist as overall cancer mortality continues to fall

Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy

After Karen Knudsen departed from the American Cancer Society late last year, the question of where she will end up becoming the fodder for cocktail party chatter throughout oncology.

April 04, 2025

Vol.51 No.13

By Paul Goldberg

Building a nationally integrated cancer research and treatment network

Cancer care is at an inflection point. The traditional boundaries between academic and community oncology are dissolving, requiring a reimagined approach to patient care and clinical research. At City of Hope, we are implementing a national model that integrates breakthrough research with accessible, advanced treatment across diverse geographic regions.

Health innovation and health equity: Ensuring technologies advance resilience, justice, and compassionate care

Technological innovations are often hailed as transformative tools capable of revolutionizing healthcare. From gene editing for conditions like sickle cell disease to AI predicting hospital readmissions, to telemedicine expanding healthcare access, these advancements have the potential to change the way we treat diseases.

March 21, 2025

Vol.51 No.11

By Jamillah Hoy-Rosas

In the Archives

In 1990, “political oncologist” Helene Brown predicted the future. Did she get it right?

When Helene Brown, a cancer control pioneer who jokingly described herself as “the first in a long line of political oncologists,” delivered the keynote address at the Oncology Nursing Society annual meeting in 1990, she set forth bold predictions for the ensuing 20 years of the field: appointments conducted over “computerphone,” major genetic breakthroughs, and universal healthcare.

Matthew J. Carpenter named associate director of the Cancer Prevention & Control Research Program at MUSC

Matthew J. Carpenter was named associate director of the Cancer Prevention & Control Research Program at MUSC Hollings Cancer Center.

March 21, 2025

Vol.51 No.11

In Brief

UA research team receives $1.2M ACS grant to study link between neighborhood environment and cancer risk

A University of Arizona Mel and Enid Zuckerman College of Public Health researcher has received a $1.2 million grant from the American Cancer Society to evaluate potential links between the neighborhood environment and cancer risk.

March 21, 2025

Vol.51 No.11

ACS report: “Alarming” health disparities in preventable cancers persist as overall cancer mortality continues to fall

YOU MAY BE INTERESTED IN

Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy

Building a nationally integrated cancer research and treatment network

Health innovation and health equity: Ensuring technologies advance resilience, justice, and compassionate care

In 1990, “political oncologist” Helene Brown predicted the future. Did she get it right?

Matthew J. Carpenter named associate director of the Cancer Prevention & Control Research Program at MUSC

UA research team receives $1.2M ACS grant to study link between neighborhood environment and cancer risk

Renew today!

Subscriber content

Never miss an issue!

Login